A Phase III Trial of Radiation Therapy with or without Casodex in Patients with PSA Elevation Following Radical Prostatectomy for pT3N0 Carcinoma of the Prostate
Principal Investigator
William Shipley, MD
Status
Terminated
Date of Study Termination
May 20 2022
Disease Site
Genitourinary [GU]
Prostate
Phase
III
Developmental Therapeutics
No
Primary Objective
Patient Population
-
Target Accrual
810
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.